In vitro and in silico identification and characterisation of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.

Roslyn S. Thelingwani, Simbarashe P. Zvada, Hugues Dolgos, Anna-Lena B. Ungell, Collen M. Masimirembwa
June 1, 2009
Learn More
LinkedIn